Daschle, Peanut Butter Put FDA Commissioner Choice In Sticky Situation
Executive Summary
The withdrawal of Tom Daschle's nomination as HHS secretary may delay the announcement of an FDA commissioner, but does not change the two names on the Obama Administration's shortlist
You may also be interested in...
FDA Should Embrace Its E-Future, Industry Reps Say
To the next FDA commissioner: your agency needs to move into the 21st century now and it can start by accepting digital drug submissions
FDA Should Embrace Its E-Future, Industry Reps Say
To the next FDA commissioner: your agency needs to move into the 21st century now and it can start by accepting digital drug submissions
FDA’s Dubious Honor: GAO Flags Many Of Its Activities As “High Risk”
FDA's White Oak campus is still far from complete, but an extreme reading of official statements during the last few weeks might suggest that it could be closed